Ozdapa 10mg Tablet
Marketer
Ozrak LifeSciences
Salt Composition
Dapagliflozin (10mg)
Overview Ozdapa 10mg Tablet
Dapagliflozin 10mg tablets are prescribed, either independently or alongside other medications, to manage type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to heart disease prevention. Dapagliflozin 10mg tablets may be administered with or without food, at any point during the day, though consistent daily timing is recommended. Dosage is determined by your physician; discontinuation should only occur under their supervision, as cessation can lead to increased blood sugar and heightened risk of complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan that incorporates a balanced diet, regular physical activity, and weight management, as directed by your doctor. Common side effects include vaginal yeast infections, nasopharyngitis, and urinary tract infections. Dehydration is possible; increased fluid intake is crucial. Practicing good hygiene helps prevent genital fungal infections. Prior to commencing treatment, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should consult their physician before use. Limit alcohol consumption, as it may exacerbate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Ozdapa 10mg Tablet
No text provided to rephrase.
Uses of Ozdapa 10mg Tablet
Managing type 2 diabetes
Major Benefits of Ozdapa 10mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ozdapa 10mg tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Ozdapa 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Ozdapa 10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ozdapa 10mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Ozdapa 10mg Tablet works:
Ozdapa 10mg tablets help manage diabetes by facilitating the excretion of surplus glucose via the urinary system.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Ozdapa 10mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ozdapa 10mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Ozdapa 10mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from operating a vehicle if such symptoms arise.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Ozdapa 10mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Ozdapa 10mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Ozdapa 10mg Tablet :
Should you forget to take your Ozdapa 10mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ozdapa 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Active Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently